Scarica l'app Stockscreener
0.7765
0.46%
-0.0036
Dopo l'orario di chiusura:
.80
0.0235
+3.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.7801
Aprire:
$0.7819
Volume 24 ore:
585.45K
Relative Volume:
0.51
Capitalizzazione di mercato:
$100.30M
Reddito:
-
Utile/perdita netta:
$-26.91M
Rapporto P/E:
-3.5295
EPS:
-0.22
Flusso di cassa netto:
$-19.57M
1 W Prestazione:
-1.33%
1M Prestazione:
-15.12%
6M Prestazione:
-6.47%
1 anno Prestazione:
-39.34%
Intervallo 1D:
$0.775
$0.80
Intervallo di 1 settimana:
$0.755
$0.80
Portata 52W:
$0.5526
$1.66
Atossa Therapeutics Inc Stock (ATOS) Company Profile
Nome
Atossa Therapeutics Inc
Settore
Industria
Telefono
206.588.0256
Indirizzo
10202 5TH AVENUE NE, SEATTLE, WA
Confronta ATOS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATOS
Atossa Therapeutics Inc
|
0.7765 | 100.77M | 0 | -26.91M | -19.57M | -0.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2018-01-26 | Iniziato | Maxim Group | Buy |
Atossa Therapeutics Inc Borsa (ATOS) Ultime notizie
Technical analysis overview for Atossa Therapeutics Inc. stockJuly 2025 Closing Moves & Target Return Focused Stock Picks - Newser
Building trade automation scripts for Atossa Therapeutics Inc.July 2025 Update & Consistent Return Strategy Ideas - Newser
Can momentum traders help lift Atossa Therapeutics Inc.2025 Year in Review & Long-Term Capital Growth Ideas - Newser
Chart overlay techniques for tracking Atossa Therapeutics Inc.Watch List & Accurate Technical Buy Alerts - Newser
What the charts say about Atossa Therapeutics Inc. todayWeekly Trend Report & Smart Money Movement Alerts - Newser
What recovery options are there for Atossa Therapeutics Inc.July 2025 EndofMonth & Pattern Based Trade Signal System - Newser
HC Wainwright Expects Reduced Earnings for Atossa Genetics - Defense World
Does Atossa Therapeutics Inc. show high probability of reboundQuarterly Profit Summary & Long Hold Capital Preservation Tips - Newser
Multi asset correlation models including Atossa Therapeutics Inc.Market Growth Summary & Fast Gain Swing Trade Alerts - Newser
Trendlines Converge — Decision Point for Atossa Therapeutics Inc.July 2025 Selloffs & Weekly High Return Stock Opportunities - beatles.ru
Published on: 2025-08-15 04:52:23 - Newser
Will Atossa Therapeutics Inc. benefit from macro trendsEarnings Trend Report & Long Hold Capital Preservation Plans - Newser
Why Atossa Therapeutics Inc. stock attracts strong analyst attentionWeekly Risk Report & Risk Controlled Daily Plans - Newser
Technical Heatmap Flags Atossa Therapeutics Inc. for WatchMarket Volume Summary & Fast Gain Swing Alerts - newsyoung.net
What makes Atossa Therapeutics Inc. stock price move sharplyBuy Signal & Low Drawdown Trading Strategies - Newser
Should you wait for a breakout in Atossa Therapeutics Inc.IPO Watch & Low Drawdown Investment Strategies - Newser
Ranking Atossa Therapeutics Inc. among high performing stocks via toolsTrade Analysis Summary & AI Optimized Trade Strategies - Newser
Atossa Therapeutics Advances Breast Cancer Treatments - TipRanks
What does recent volatility data suggest for Atossa Therapeutics Inc. [July 2025 News Drivers]Weekly Breakout Opportunity Watchlist - Newser
Atossa Therapeutics Inc. stock momentum explainedDaily Breakout List with Smart Filters - Newser
H.C. Wainwright Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $7 - 富途牛牛
Applying sector rotation models to Atossa Therapeutics Inc. [July 2025 Rallies]Risk Controlled Stock Pick Alerts - Newser
Atossa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Short Term Charts Align With Long Term Uptrend in Atossa Therapeutics Inc.Growth Based Stock Signal Screener Updated - 선데이타임즈
Atossa Therapeutics' Q2 2025 Earnings: Navigating Financial Losses and the Promise of (Z)-endoxifen in Metastatic Breast Cancer - AInvest
Atossa Therapeutics Q2 2025 Financial Results and Corporate Update - TradingView
FDA Fast-Tracks Atossa's Breast Cancer Drug as Clinical Trial Shows 77% Tumor Reduction - Stock Titan
Risk vs reward if holding onto Atossa Therapeutics Inc.Free Pattern Alert With ROI Driven Strategy - Newser
Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update - Ariva
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pensacola News Journal
How moving averages guide Atossa Therapeutics Inc. tradingEquity Market Return Forecast Model Update - Newser
New Product Launches: Will They Boost Atossa Therapeutics Inc. Stock in 2025Free Sector Rotation Based Trading Opportunities - Newser
Is Atossa Therapeutics Inc. building a consolidation baseTrade Signal Summary & Consistent Profit Trade Alerts - Newser
What does recent volatility data suggest for Atossa Therapeutics Inc.Secure Trading Strategy Based on Technical Analysis - Newser
Atossa Therapeutics Inc. Uptrend in Early Stages Indicators Say YesReversal Alert Based on RSI Indicator Confirmed - beatles.ru
Published on: 2025-08-09 01:47:05 - Newser
Atossa Genetics (ATOS) Expected to Announce Earnings on Monday - Defense World
Atossa Therapeutics Inc Azioni (ATOS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Atossa Therapeutics Inc Azioni (ATOS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Remmel H. Lawrence | Director |
Mar 26 '25 |
Buy |
0.70 |
10,000 |
7,000 |
10,257 |
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):